International Clinical Trial: Clinical outcomes of septic shock patients receiving methylene blue with vasopressor catecholamine versus catecholamine alone: A randomized controlled trial

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20251007014) titled 'Clinical outcomes of septic shock patients receiving methylene blue with vasopressor catecholamine versus catecholamine alone: A randomized controlled trial' on Oct. 7.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Thanapat Tantraporn

Condition: Early administration of methylene blue in patients with septic shock who require vasopressor support septic shock, methylene blue septic shock, methylene blue

Intervention: Drug and Dose: Methylene blue 100 mg

Dilution: In 500 mL 5 percent dextrose in water

Infusion rate: Over 6 hours

Frequency and Duration: Once daily for three consecuti...